(Reuters) - Omeros Corp said the U.S. Food and Drug Administration approved its drug for use in cataract and lens replacement surgeries. The company said it plans to launch the drug, Omidria, later this year in the United States. (Reporting by Natalie Grover in Bangalore; Editing by Joyjeet Das)
via Health News Headlines - Yahoo News http://ift.tt/1hQfA7X
via Health News Headlines - Yahoo News http://ift.tt/1hQfA7X
No comments:
Post a Comment